Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 92 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
911 12.3 months Metastatic colorecal cancer 5 Biologic therapy
Chemotherapy
Rocky Mountain Cancer Center United States 3/2013
Treatment Details: Patients: This phase 2 study involved patients with previously treated metastatic colorectal cancer with the KRAS mutation. These patients were divided into three separate treatment groups.
 
912 12.3 months Metastatic melanoma 5 Biologic therapy
Chemotherapy
Saint John's Health Center United States 1/2012
Treatment Details: Patients: This phase II study involved previously untreated metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 71 patients with a median
 
913 12.3 months Metastatic melanoma 5 Biologic therapy
Chemotherapy
Mayo Clinic United States 8/2012
Treatment Details: Patients: This phase 2 study involved previously untreated metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 42 patients with a median
 
914 12.3 months Advanced colorectal cancer 4 Biologic therapy
Ospedale S. Martino Italy 4/2008
Treatment Details: Patients: This phase II study involved thirty-nine patients with advanced colorectal cancer. Most (30) of the patients were men. The median age was 73 years, ranging from 49 to 84 years.
 
915 12.3 months Advanced NSCLC 4 Chemotherapy
Immunotherapy
University Medical Center Mannheim Germany 8/2008
Treatment Details: Patients: This phase 2 study involved 112 patients with stage IIIB or IV non-small cell lung cancer. They were divided into two treatment groups. One group had a median age of 65, the oth
 
916 12.3 months Triple-negative Metastatic breast cancer 5 Biologic therapy
Chemotherapy
Baylor Charles A. Sammons Cancer Center United States 1/2011
Treatment Details: Patients: This study involved women with triple-negative metastatic breast cancer, which is type of cancer that does not have estrogen receptor (ER-), progesterone receptor (PR-), or an abu
 
917 12.3 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Johns Hopkins United States 7/2002
Treatment Details: Patients: This Phase II study involved 50 newly diagnosed glioblastoma multiforme patients. Treatment: Treatment consisted of RSR13 (efaproxiral) and standard cranial radiotherapy. RSR1
 
918 12.2 months relapsed ovarian cancer 4 Chemotherapy
Fox Chase Cancer Center United States 8/2005
Treatment Details: Patients: This Phase II study involved 30 patients, of which 27 were evaluated. The median age was 61. 23 patients had ovarian cancer and 4 had primary peritoneal cancer. Treatment: T
 
919 12.2 months Metastatic melanoma 4 Chemotherapy
Immunotherapy
University of Schleswig-Holstein Germany 7/2008
Treatment Details: Patients: This phase II study involved 28 patients with metastatic melanoma. There were 16 men and 12 women. The median age was 56, ranging from 42 to 69 years old. Treatment: Patients
 
920 12.2 months Castration-resistant prostate cancer 3 Biologic therapy
BC Cancer Agency Canada 4/2008
Treatment Details: Patients: This phase II study involved 28 men with castration-resistant prostate cancer. All had been treated with hormonal therapy, 18 had been treated with radiation therapy, but none ha
 
Page 92 of 187  | Previous Page  | Next Page